EFTA01461549.pdf
dataset_10 PDF 51.9 KB • Feb 4, 2026 • 1 pages
As of 4/16/14 11;23 pm PX_LAST
Description Trade Date Quantity Current Price Unit Cost Market Value Current Total Cost Unrealized G/L
SANGAMO BIOSCIENCES 5/28/2013 50,000.00 $ 14.12 $ 8.44 $ 706,000.00 422,214.00 $ 283,786.00
BIOGEN 2/14/2012 2,095.00 $ 290.72 $ 119.55 $ 609,058.40 250,454.95 $ 358,603.45
FOUNDATION MEDICINE 1/13/2014 25,000.00 $ 27.27 $ 27.51 $ 681,625.00 687,663.50 $ (6,038.50)
GILEAD SCIENCES INC Multiple 8,100.00 $ 69.31 $ 79.41 $ 561,402.90 643,204.00 $ (81,801.10)
Total Biotech $ 2,558,086.30 $ 2,003,536.45 $ 554,549.85
ARIAD PHARMACEUTICALS Multiple 16,535.00 $ 6.83 5 17.60 $ 112,934.05 290,997.40 S (178,063.35)
CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e) DB-SDNY-0123673
CONFIDENTIAL SDNY_GM_00269857
EFTA01461549
Entities
0 total entities mentioned
No entities found in this document
Document Metadata
- Document ID
- 3250c1d3-7f7e-47c7-b9e6-68e269074c6f
- Storage Key
- dataset_10/93cf/EFTA01461549.pdf
- Content Hash
- 93cfcfa1bd60e75024ced58147e03105
- Created
- Feb 4, 2026